Clinical Trial

Chest CT Scan in Pulmonary Mucormycosis: Prognostic Value

Study acronym: RadioMucor
Recruiting
View on ClinicalTrials.gov →
Summary
Invasive pulmonary fungal infections caused by Mucorales are rare but severe and rapidly progressive, affecting immunocompromised patients. The role of chest imaging in their diagnosis is well established in the 2020 EORTC/MSGERC criteria, and its use is almost systematic. However, the progression of lung parenchymal involvement and any potential prognostic radiological patterns in the follow-up of these infections are less well understood. This research aims to identify imaging characteristics predictive of favorable or unfavorable outcomes in infected patients, in order to better tailor follow-up and therapeutic options.
Trial Details
NCT Number NCT07339800
Lead Sponsor University Hospital, Strasbourg, France
Conditions Pulmonary Mucormycosis
Enrollment 80 participants
Start Date 2025-09-18
Primary Completion 2026-09 (estimated)
Study Completion 2026-09-19 (estimated)
Updated on ClinicalTrials.gov 2026-01-14